Cardiometabolic Index: a novel prognostic biomarker for recurrent stroke risk in acute ischemic stroke patients - Takeaways - MDSpire

Cardiometabolic Index: a novel prognostic biomarker for recurrent stroke risk in acute ischemic stroke patients

  • By

  • Yue Wang

  • Yingying Ding

  • Min Han

  • Yehong Liu

  • Tao Xin

  • June 10, 2026

  • 0 min

Share

  • 1

    Stroke is a significant global health issue, with recurrent stroke being a serious complication for patients with acute ischemic stroke (AIS).

  • 2

    The study involved 588 AIS patients who received thrombolytic therapy, assessing the Cardiometabolic Index (CMI) as a prognostic biomarker.

  • 3

    CMI showed superior predictive performance for long-term adverse cerebrovascular events compared to traditional biomarkers in post-thrombolytic AIS patients.

  • 4

    A high CMI value (≥0.80) was independently associated with an increased risk of major adverse cerebrovascular events (MACEs).

  • 5

    Systemic inflammation partially mediated the predictive effect of CMI on adverse clinical outcomes in AIS patients after thrombolytic therapy.

Original Source(s)

Cardiometabolic Index: a novel prognostic biomarker for recurrent stroke risk in acute ischemic stroke patients

  • by Yue Wang, Yingying Ding, Min Han, Yehong Liu, Tao Xin

  • June 10, 2026

Related Content

Progress in research on the association between glucose metabolism disorders and intracranial and extracranial atherosclerotic stenosis

Safety and efficacy of intravenous tPA after successful thrombectomy for large vessel occlusion: a retrospective study

Mass Spec Roundup: Ubiquitin, Pollutants, and Pain

Non-protein ubiquitination, cryogenic chemical mapping, wastewater antidepressants, and new molecular clues to post-stroke pain

  • June 10, 2026

  • 6 min